Ainos Inc (AIMD)vsCoherent Inc (COHR)
AIMD
Ainos Inc
$1.38
+0.73%
TECHNOLOGY · Cap: $10.56M
COHR
Coherent Inc
$289.65
+6.92%
TECHNOLOGY · Cap: $57.41B
Smart Verdict
WallStSmart Research — data-driven comparison
Coherent Inc generates 52339466% more annual revenue ($7.12B vs $13,600). COHR leads profitability with a 11.3% profit margin vs 0.0%. COHR appears more attractively valued with a PEG of 0.92. COHR earns a higher WallStSmart Score of 62/100 (C+).
AIMD
Avoid25
out of 100
Grade: F
COHR
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for AIMD.
Margin of Safety
-86.0%
Fair Value
$164.21
Current Price
$289.65
$125.44 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Growing faster than its price suggests
Revenue surging 33.7% year-over-year
Earnings expanding 73.0% YoY
Large-cap with strong market position
Growing faster than its price suggests
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Grey zone — moderate risk
ROE of 7.4% — below average capital efficiency
Premium valuation, high expectations priced in
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : AIMD
The strongest argument for AIMD centers on PEG Ratio. PEG of 0.93 suggests the stock is reasonably priced for its growth.
Bull Case : COHR
The strongest argument for COHR centers on Revenue Growth, EPS Growth, Market Cap. Revenue growth of 33.7% demonstrates continued momentum. PEG of 0.92 suggests the stock is reasonably priced for its growth.
Bear Case : AIMD
The primary concerns for AIMD are EPS Growth, Market Cap, Profit Margin. Debt-to-equity of 4.21 is elevated, increasing financial risk.
Bear Case : COHR
The primary concerns for COHR are Altman Z-Score, Return on Equity, P/E Ratio. A P/E of 71.0x leaves little room for execution misses.
Key Dynamics to Monitor
AIMD profiles as a value stock while COHR is a growth play — different risk/reward profiles.
AIMD carries more volatility with a beta of 2.48 — expect wider price swings.
COHR is growing revenue faster at 33.7% — sustainability is the question.
AIMD generates stronger free cash flow (-1M), providing more financial flexibility.
Bottom Line
COHR scores higher overall (62/100 vs 25/100) and 33.7% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Ainos Inc
TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA
Ainos, Inc., a healthcare company, is dedicated to the development of medical technologies for safe and novel point-of-care testing and medical treatment for disease indications. The company is headquartered in San Diego, California.
Coherent Inc
TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA
Coherent, Inc. provides lasers, laser-based technologies, and laser-based system solutions for a variety of scientific, commercial, and industrial research applications. The company is headquartered in Santa Clara, California.
Compare with Other SCIENTIFIC & TECHNICAL INSTRUMENTS Stocks
Want to dig deeper into these stocks?